EMEA-001373-PIP01-12-M03
Key facts
Invented name |
Mysimba
|
Active substance |
|
Therapeutic area |
Other
|
Decision number |
P/0365/2017
|
PIP number |
EMEA-001373-PIP01-12-M03
|
Pharmaceutical form(s) |
Prolonged-release tablet
|
Condition(s) / indication(s) |
Treatment of obesity
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Orexigen Therapeutics Ireland Limited
Tel. +1 8588758600
E-mail: ir@orexigen.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|